Data is not available at this time.
Zeon Corporation operates as a diversified specialty chemicals company with a strong focus on elastomers, specialty materials, and advanced electronic components. The company's core revenue model is built on high-performance synthetic rubbers, latex products, and specialty chemicals, serving industries such as automotive, construction, electronics, and healthcare. Its synthetic rubbers, including NBR and hydrogenated NBR, are critical for tire manufacturing, while its latex products cater to adhesives, paints, and medical gloves, positioning Zeon as a key supplier in these niche markets. The company further diversifies its portfolio with electronic materials for semiconductors and rechargeable batteries, as well as specialty plastics for optical and medical applications. With a global footprint, Zeon licenses proprietary technologies in over 23 countries, reinforcing its competitive edge in resource-efficient chemical solutions. The firm’s strategic focus on innovation and sustainability, such as its PENTAM molded products, enhances its market positioning as a leader in energy-saving materials. This multi-pronged approach allows Zeon to maintain resilience across economic cycles while capitalizing on growth in high-tech and industrial sectors.
Zeon Corporation reported revenue of JPY 420.6 billion for FY2025, with net income of JPY 26.2 billion, reflecting a net margin of approximately 6.2%. The company's operating cash flow stood at JPY 20.8 billion, though capital expenditures of JPY -31.2 billion indicate significant reinvestment. Diluted EPS of JPY 127.37 underscores steady profitability, supported by disciplined cost management and a diversified product mix.
The company demonstrates consistent earnings power, driven by its high-margin specialty materials and elastomers segments. With a beta of 0.136, Zeon exhibits lower volatility compared to the broader market, suggesting stable cash flows. Capital efficiency is balanced between growth investments and maintaining liquidity, as seen in its JPY 27.4 billion cash reserves against JPY 25.9 billion in total debt.
Zeon maintains a conservative balance sheet, with JPY 27.4 billion in cash and equivalents offset by JPY 25.9 billion in total debt, indicating a manageable leverage ratio. The firm’s financial health is further supported by positive operating cash flow, providing flexibility for strategic initiatives and dividend payments.
Zeon’s growth is anchored in innovation, particularly in electronic materials and sustainable solutions. The company pays a dividend of JPY 70 per share, reflecting a commitment to shareholder returns. While capex remains elevated, its focus on high-growth niches like battery materials and medical devices positions it for long-term expansion.
With a market cap of JPY 278.8 billion, Zeon trades at a moderate valuation, reflecting its stable earnings and niche market leadership. Investors likely anticipate steady growth from its specialty chemicals and electronic materials segments, balanced by cyclical exposure to automotive and industrial demand.
Zeon’s strategic advantages lie in its technological expertise, diversified product portfolio, and global licensing footprint. The outlook remains positive, driven by demand for advanced materials in electronics and healthcare, though macroeconomic volatility in raw material costs could pose challenges. Its focus on sustainability and innovation positions it well for future growth.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |